Oncology Medical News about zoledronic acid

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials

4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Clinical efficacy and safety of zoledronic acid in prostate and breast cancer
Expert Review of Anticancer Therapy, 09/24/09

Doggrell SA – The anti–estrogen treatment for hormone–sensitive breast cancer and the androgen deprivation therapy for prostate cancer can lead to the development of osteoporosis and bone fractures. The efficacy and safety of zoledronic acid in osteoporosis secondary to hormone–sensitive cancers (prostate and breast), and in the bone metastases associated with these cancers are reviewed.

<< Previous
Development of the Berlin Symptom Checklist Ovary (BSCL-O) for...

Next >>
Sentinel lymph node examination for cancer of the uterine cervix

Is zoledronic acid an anticancer drug
Expert Opinion in Pharmacotherapy, 10/05/09 Relevance Score: 69%

Zoledronic Acid for the Prevention of Bone Loss in Postmenopausal Women With Low Bone Mass: A Randomized Controlled Trial
Obstetrics and Gynecology, 10/27/09 Relevance Score: 66%

Intravenous Zoledronic Acid to Prevent Osteoporosis in a Veteran Population With Multiple Risk Factors for Bone Loss on Androgen Deprivation Therapy
The Journal of Urology, 10/16/09 Relevance Score: 66%

Combination of Two Medications Help Postmenopausal Women with Osteoporosis
MedLinePlus, 10/30/09 Relevance Score: 64%

Orbital inflammatory disease secondary to a single-dose administration of zoledronic acid for treatment of postmenopausal osteoporosis
Osteoporosis International, 10/30/09 Relevance Score: 64%